View Cart
My AccountInfectious Disease Diagnostic Solutions
Microbix Phone+1803294983432Microbix Emailcustomer.service@microbix.com
Microbix Logo
Request Catalogue Contact Us
  • Services
    • Assay Development Solutions
    • Custom Vial Filling Services
  • Products
    • Reference Materials (QUANTDxâ„¢)
    • Antigens
      • All Antigens
      • Childhood Disease Antigens
      • Dengue Antigens
      • STI Antigens
      • ToRCH Antigens
      • Respiratory Antigens
      • Other Antigens
    • External Quality Controls (QAPsâ„¢)
      • All External QC Products
      • Respiratory Viral Panel
      • STI Panel
      • HPV Panel
      • Gastrointestinal Panel
      • Genital Ulcer Panel
      • Vaginal Infections Panel
      • ONBOARDx Kits
      • Proficiency Testing Panel
      • Technical Resources
    • DxTMâ„¢ Viral Transport Medium
    • Control Elution Buffer
    • Kinlytic (Urokinase)
  • About
    • Who We Are
    • Who We Work With
    • Quality
    • Board of Directors
    • Our Senior Team
    • Careers
  • Resources
    • Catalogues & Brochures
    • White Papers
    • Poster Publication
    • Podcasts
  • Investors
    • News Releases
    • Financial Reports
    • Corporate Presentations
    • Analyst Coverage
    • Corporate Governance
    • Stock Information
Contact Us
Microbix’s AGM 2026

Microbix’s AGM 2026

by Shitika Kulshreshtha | Feb 19, 2026 | Events, Media Featured Upcoming Events

Microbix will be hosting an AGM on March 25, 2026, at 1:00 pm (EST) at Hyatt Place Mississauga Centre, 5787 Hurontario Street, Mississauga, Ontario L4Z 2H7.   The online link will allow shareholders to listen to the AGM and view a CEO presentation via Zoom....
Microbix Reports Results for Q1 2026

Microbix Reports Results for Q1 2026

by Shitika Kulshreshtha | Feb 12, 2026 | Blog, Media Features News Releases, News Releases

Q1 Revenues of $4.2 million and Controlled Net Loss   MISSISSAUGA, CANADA, February 12, 2026 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its first quarter of...
Microbix Updates Investor Presentation on its Website

Microbix Updates Investor Presentation on its Website

by Shitika Kulshreshtha | Jan 9, 2026 | Blog, News Releases

In Response to OSC Requirements to Explain EBITDA (a non-IFRS measure)   MISSISSAUGA, CANADA, January 9, 2026 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it has...
Microbix Commercializes SARS-CoV-2 (COVID) Recombinant Antigen

Microbix Commercializes SARS-CoV-2 (COVID) Recombinant Antigen

by Shitika Kulshreshtha | Jan 7, 2026 | News Releases

For Usage in QAPs and Test Manufacturing   MISSISSAUGA, CANADA, January 7, 2026 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces the commercial usage of its first recombinant antigen...
Microbix Reports Results for Q4 and Fiscal 2025

Microbix Reports Results for Q4 and Fiscal 2025

by Shitika Kulshreshtha | Dec 18, 2025 | News Releases

Full-Year Revenues of $18.6 million and Net Loss of $2.2 million   MISSISSAUGA, CANADA, December 18, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its fiscal...
« Older Entries
  • Investors
  • Legal
  • Contact
  • News Releases
  • Accessibility
  • Careers
Microbix Funded By
Lab Image Lab Image

Get the Latest from Microbix—Straight to Your Inbox!

Stay up to date with news releases, product updates, tradeshows and conference information, and newsletters.


    Maybe later, science waits for no one